EU
ALNY icon

Emory University’s Alnylam Pharmaceuticals ALNY Stock Holding History

Emory University’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-31,959
Closed -$2.33M – 46
2018
Q4 		$2.33M Buy
31,959
+4,275
+15% +$329K 1.84% 12
2018
Q3 		$2.42M Buy
27,684
+1,428
+5% +$144K 1.59% 27
2018
Q2 		$2.59M Buy
26,256
+4,940
+23% +$490K 1.72% 19
2018
Q1 		$2.54M Buy
21,316
+6,972
+49% +$899K 1.81% 17
2017
Q4 		$1.82M Sell
14,344
-6,316
-31% -$794K 1.56% 30
2017
Q3 		$2.43M Sell
20,660
-922
-4% -$78.7K 1.92% 5
2017
Q2 		$1.72M Buy
+21,582
New +$1.38M 1.52% 11

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Emory University's ALNY Position: Q1 2019 in Review

Emory University sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2019, closing a stake of 31,959 shares — an estimated $2.33M sold.

Emory University first reported a position in ALNY in Q2 2017 and held it in 7 quarters. The position peaked at $2.59M in Q2 2018. 291 funds tracked by Wall St. Rank hold ALNY as of Q1 2019.

  • Emory University reported no remaining Alnylam Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Emory University sold 31,959 Alnylam Pharmaceuticals shares in Q1 2019, an estimated $2.33M.
  • Emory University first reported a position in Alnylam Pharmaceuticals in Q2 2017 and held it in 7 quarters.
  • Emory University's Alnylam Pharmaceuticals position peaked at $2.59M in Q2 2018.
  • 291 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2019.

Based on Emory University's 13F filing for Q1 2019, filed 9 May 2019.